« Previous | All Messages |  ADLI Message Board Home | recommend post |  Ignore Poster

ADLI News American Medical Technologies Expands International Dealers and Sales Management Team

CORPUS CHRISTI, Texas--(BUSINESS WIRE)--American Medical Technologies, Inc. (“AMT”) (OTCBB:ADLI) announced today the appointment of Mark E. Sernatinger as Director of Sales, The Americas and Scott G. Juhl as Director of Sales, Europe, Middle East and Africa.

“AMT has recently expanded its global reach into 15 new countries by adding 10 new distributors in Asia Pac, Latin America and EMEA. With these additions we are now in 48 countries and our network consists of 31 distributors world wide. AMT is pleased to have Mark and Scott join our global sales management team to continue the implantation of our aggressive international growth plan into 2007,” stated Judd D. Hoffman, Vice President of World Wide Sales and Operations.

Mark E. Sernatinger joins the AMT team as an expert in Latin American and U.S. business development. In the dental industry, Mr. Sernatinger has a strong track record managing the Latin American and distribution network for Discus Dental and other health and dental companies. Mr. Sernatinger has earned an undergraduate degree and an MBA in International Business. He is fluent in Spanish and Portuguese.

Scott G. Juhl joins AMT with strong international sales and marketing management experience in the dental, cosmeceutical and fluid sealing industries. Mr. Juhl has a successful track record in increasing sales through the development and management of international distribution networks, working as Director of Sales and Marketing for such notable companies as Discus Dental and SGL Carbon. He has an undergraduate degree in Business Administration and a post graduate certificate in Executive Management from the Anderson School at UCLA.

“AMT is entering into a new phase of aggressive growth in the global market and we are establishing a strong management team to drive this effort," stated Roger W. Dartt, President and Chief Executive Officer.

AMT develops, manufactures and markets the high-technology dental products utilizing a patented Hydrobrasion™ technique and recently acquired the exclusive worldwide distribution rights to the Spectrum Dental tooth whitening product line.

The Company makes forward-looking statements in this press release and in its filings with the Securities and Exchange Commission. The Company’s forward-looking statements are subject to risks and uncertainties and include information about its expectations and possible or assumed future results of operations. When the Company uses any of the words “believes,” “expects,” “anticipates,” “estimates” or similar expressions, it is making forward-looking statements.

The Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all of its forward-looking statements. While the Company believes that its forward-looking statements are reasonable, you should not place undue reliance on any such forward-looking statements, which speak only as of the date made. Because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond the Company’s control or are subject to change, actual results could be materially different. Factors that might cause such a difference include, without limitation, the following: the Company’s inability to generate sufficient cash flow to meet its current liabilities, the Company’s potential inability to hire and retain qualified sales and service personnel, the potential for an extended decline in sales, the possible failure of revenues to offset additional costs associated with its change in business model, the potential lack of product acceptance, the Company’s potential inability to introduce new products to the market, the potential failure of customers to meet purchase commitments, the potential loss of customer relationships, the potential failure to receive or maintain necessary regulatory approvals, the extent to which competition may negatively affect prices and sales volumes or necessitate increased sales expenses, and the other risks and uncertainties set forth in this report.

Other factors not currently anticipated by management may also materially and adversely affect the Company’s results of operations. Except as required by applicable law, the Company does not undertake any obligation to publicly release any revisions which may be made to any forward-looking statements to reflect events or circumstances occurring after the date of this report.